Cure My Disease

Don't miss your cure!

 Log in / Sign up

New alpha therapy shows promise for deadly brain cancer

NCT ID NCT07488754

Recruiting now Disease control Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new treatment for aggressive brain tumors (glioblastoma) that uses a radioactive substance attached to a targeting molecule. The therapy is given directly into the tumor area after standard treatments like surgery and chemotherapy. The goal is to see if it can help people live longer and keep the tumor from growing back. The study involves 35 adults aged 18-80 with high-grade glioma.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma glioma malignant glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOBLASTOMA GLIOBLASTOMA (GBM) HIGH-GRADE GLIOMA (WHO III-IV)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Neurosurgery, Medical University of Warsaw, Banacha 1a

    RECRUITING

    Warsaw, Poland, 02-097, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Neurosurgery, National Instiute of Oncology, W.K. Roentgena 5

    RECRUITING

    Warsaw, Poland, 02-781, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.